Germany is the largest market for proton therapy in the European region. Currently, six proton therapy centers are operational in Germany. Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge potential market. Germany represents a huge untapped market opportunity for proton therapy. The number of patients treated with proton therapy in Germany is very low whereas; the potential candidates for proton therapy are huge.

iGATE RESEARCH report titled “Germany Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022” provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy Market.

This 57 Page report with 15 Figures and 1 Table has been analyzed from 4 View Points:

1. Actual and Potential Proton Therapy Market (2009 - 2022)
2. Actual and Potential Candidate for Proton Therapy Treatment (2009 - 2022)
3. List of Proton Therapy Centers
4. Proton Therapy Market - Drivers and Challenges

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

1. Executive Summary

2. Germany Proton Therapy Market Analysis

2.1 Germany Proton Therapy - Actual and Potential Market (2009 - 2022)

2.1.1 Germany - Actual Proton Therapy Market and Forecast
2.1.2 Germany - Potential Proton Therapy Market and Forecast

2.2 Germany Proton Therapy Patients Number - Actual and Potential (2009 - 2022)

2.2.1 Germany - Patients Treated with Proton Therapy Actual Number and Forecast
2.2.2 Germany - Potential Candidate for Proton Therapy Number and Forecast

3. Germany - List of Proton Therapy Centers, Start of Treatment, Patient Treated

4. Germany – Number of Patients Treated at Proton Therapy Centers

4.1 Universitatklinikum Carl Gustav Carus, Dresden, Germany - Number of Patients Treated (2014 – 2015)
4.2 Westdeutsches Protonentherapie zentrum Essen (WPE), Essen, Germany - Number of Patients Treated (2013 – 2015)
4.3 Rinecker Proton Therapy Center, Munich, Germany - Number of Patients Treated (2009 – 2015)
4.4 HMI Berlin, Germany - Number of Patients Treated (2007 – 2015)
4.5 Heidelberger Ionenstrahl-Therapiezentrum (HIT), Germany - Number of Patients Treated (2010 – 2015)

5. Current Radiation Therapies

5.1 Third Dimensional Conformal Therapy (CRT)
5.2 Image Guided Radiotherapy (IGRT)
5.3 Intensity Modulated Radiotherapy (IMRT)
5.4 Stereotactic Radiotherapy
5.5 Neutron Therapy
5.6 Heavy Ion Radiotherapy
5.7 Proton Therapy

6. Components of a Standard Proton Therapy Center

6.1 Proton Accelerator
6.2 Beam Transport System
6.3 Beam Delivery System
6.3.1 The Passive Scattering Technique
6.3.2 Beam Scanning
6.4 Nozzle
6.4.1 Single Scattering
6.4.2 Double Scattering
6.4.3 Uniform Scanning Nozzle
6.4.4 Pencil Scanning Nozzle
6.5 Treatment Planning System
6.6 Image Viewers
6.7 Patient Positioning System (PPS)
6.8 Human Resource

7. Proton Therapy - Driving Factors

7.1 Technology Advancement
7.1.1 Next-Generation Proton Technique
7.1.2 Technological Advances Make Proton Therapy Centers More Scalable
7.2 Growing Incidence of Cancer Patients
7.3 Proton Therapy Provides Enormous Benefits

8. Proton Therapy - Challenges

8.1 Requires Huge Investment
8.2 Operations Challenges
8.3 More Clinical Evidence Is Needed